Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Agitation Associated With Alzheimer's Dementia
Clinical Trial
NCT06651567Last updated: 12/4/2025
ITCI
Intra-Cellular Therapies, Inc.
